Informed Consent Elements
Document ID: FDA-2009-N-0592-0001
Comments
Total: 63
-
Methodist Healthcare System IRB - Comment
Posted : 01/07/2010 ID ：FDA-2009-N-0592-0006 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Methodist Healthcare - Comment
Posted : 01/07/2010 ID ：FDA-2009-N-0592-0007 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Brigette White - Comment
Posted : 01/08/2010 ID ：FDA-2009-N-0592-0008 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
James Barker - Comment
Posted : 01/08/2010 ID ：FDA-2009-N-0592-0009 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Anonymous - Comment
Posted : 01/19/2010 ID ：FDA-2009-N-0592-0010 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Day Werts - Comment
Posted : 01/25/2010 ID ：FDA-2009-N-0592-0011 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Norman M Goldfarb - Comment
Posted : 01/25/2010 ID ：FDA-2009-N-0592-0012 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Quintin Loden Whitaker - Comment
Posted : 01/28/2010 ID ：FDA-2009-N-0592-0013 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Krell Clinical Communications - Comment
Posted : 02/02/2010 ID ：FDA-2009-N-0592-0014 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Kathy McClelland - Comment
Posted : 02/03/2010 ID ：FDA-2009-N-0592-0015 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Lauri Che Kelly - Comment
Posted : 02/04/2010 ID ：FDA-2009-N-0592-0016 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
David Forster - Comment
Posted : 02/04/2010 ID ：FDA-2009-N-0592-0017 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
American Red Cross - Comment
Posted : 02/04/2010 ID ：FDA-2009-N-0592-0018 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Steven Charles Schurr - Comment
Posted : 02/05/2010 ID ：FDA-2009-N-0592-0019 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Clare Matti - Comment
Posted : 02/09/2010 ID ：FDA-2009-N-0592-0020 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Fred Eugene Longenecker - Comment
Posted : 02/11/2010 ID ：FDA-2009-N-0592-0021 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Anonymous - Comment
Posted : 02/16/2010 ID ：FDA-2009-N-0592-0022 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Quintiles - Comment
Posted : 02/16/2010 ID ：FDA-2009-N-0592-0023 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Stacey Berg - Comment
Posted : 02/17/2010 ID ：FDA-2009-N-0592-0024 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Erica Heath - Comment
Posted : 02/19/2010 ID ：FDA-2009-N-0592-0025 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
McLean Hospital - Comment
Posted : 02/23/2010 ID ：FDA-2009-N-0592-0026 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
McLean Hospital - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0027 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Amanda Kimsey - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0028 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
AABB - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0029 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Association of Clinical Research Organizations (ACRO) - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0030 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Public Responsibility in Medicine and Research - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0031 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
America’s Blood Centers (ABC) - Comment - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0032 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Johns Hopkins University School of Medicine - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0033 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Kaiser Permanente - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0034 Agency : FDA -
Mar 01,2010 11:59 PM ET
-
Megan Rowlett - Comment
Posted : 03/01/2010 ID ：FDA-2009-N-0592-0035 Agency : FDA -
Mar 01,2010 11:59 PM ET